Halozyme Therapeutics Inc. logo

Halozyme Therapeutics Inc.

HALO · United States

halozyme.com

Financials as of FY2025

What stands out
  • Returns appear driven by leverage
At a glance
  • Depends onUpstream position: supplies 6 industries, depends on 3
  • ScaleMarket cap is $14.53B, above the global median of $1.14B
  • PositionOperating margin is 59.8%, higher than 95% of its Biotechnology peers (median 13.5%)
  • Interpretations20 currently firing — 20